These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18391834)

  • 1. Characteristics of nasal epithelial cells in naturally postmenopausal women receiving hormone therapy with 1 mg 17beta-estradiol and 2 mg drospirenone: a prospective study.
    Caruso S; Serra A; Grillo C; Maiolino L; Agnello C; Di Mari L; Cianci A
    Menopause; 2008; 15(5):963-6. PubMed ID: 18391834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17beta-estradiol and 2 mg drospirenone HT.
    Caruso S; Serra A; Grillo C; De Leo V; Maiolino L; Agnello C; Cianci A
    Menopause; 2008; 15(5):967-72. PubMed ID: 18551084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study on the cytological aspects of the nasal respiratory epithelium in premenopausal women taking 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive.
    Caruso S; Serra A; Grillo C; Agnello C; Di Mari L; Cianci A
    Contraception; 2008 May; 77(5):344-9. PubMed ID: 18402850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F; Dilek U; Pata O; Dilek S
    J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estradiol-drospirenone on ocular and nasal functions in postmenopausal women.
    Coksuer H; Ozcura F; Oghan F; Haliloglu B; Coksuer C
    Climacteric; 2011 Aug; 14(4):482-7. PubMed ID: 21281244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris.
    Knuuti J; Kalliokoski R; Janatuinen T; Hannukainen J; Kalliokoski KK; Koskenvuo J; Lundt S
    Am J Cardiol; 2007 Jun; 99(12):1648-52. PubMed ID: 17560868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of drospirenone/estradiol on steroid receptors and Bcl-2 in the postmenopausal endometrium.
    Lima SM; Reis BF; Yamada SS; Postigo S; Grande RM; Botogoski SR; Campaner AB; Hueb CK; Galvão MA
    Climacteric; 2011 Oct; 14(5):551-7. PubMed ID: 21469974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added benefits of drospirenone for compliance.
    Foidart JM
    Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drospirenone/estrogen combinations on bone metabolism.
    Christiansen C
    Climacteric; 2005 Oct; 8 Suppl 3():35-41. PubMed ID: 16203654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
    Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
    Palacios S; Foidart JM; Genazzani AR
    Maturitas; 2006 Nov; 55(4):297-307. PubMed ID: 16949774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic aspects of the nasal respiratory epithelium in postmenopausal women treated with hormone therapy.
    Caruso S; Roccasalva L; Di Fazio E; Sapienza G; Agnello C; Ficarra S; Di Mari L; Serra A
    Fertil Steril; 2003 Mar; 79(3):543-9. PubMed ID: 12620437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospirenone therapy on metabolic variables and markers of endothelial function in early postmenopause.
    Casanova G; Radavelli S; Lhullier F; Spritzer PM
    Fertil Steril; 2009 Aug; 92(2):605-12. PubMed ID: 18706557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women.
    Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H
    Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drospirenone and estradiol: a new option for the postmenopausal woman.
    Archer DF
    Climacteric; 2007 Feb; 10 Suppl 1():3-10. PubMed ID: 17364592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.
    Foidart JM; Faustmann T
    Gynecol Endocrinol; 2007 Dec; 23(12):692-9. PubMed ID: 18075844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
    Archer DF
    J Reprod Med; 2007 Feb; 52(2 Suppl):159-64. PubMed ID: 17477110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.